Insight Molecular Diagnostics nimmt an virtuellem U.S. Bancorp I BTIG Kidney Health Forum teil

Von Public Technologies12:02 (UTC), 12 Oktober 2026 Aktualisiert

Insight Molecular Diagnostics nimmt am 14. Oktober 2026 am virtuellen U.S. Bancorp I BTIG Kidney Health Forum teil.
Geplant sind eine virtuelle KOL-Diskussion um 12.00 Uhr ET sowie Einzelgespräche mit Investoren.
Auf dem Podium: CEO Josh Riggs; KOL Prof. Dr. Med. Klemens Budde (Charité – Universitätsmedizin Berlin).

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insight Molecular Diagnostics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610120800PRIMZONEFULLFEED9843138) on October 12, 2026, and is solely responsible for the information contained therein.